Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pure Bioscience (PURE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 34,358
  • Shares Outstanding, K 71,580
  • Annual Sales, $ 1,770 K
  • Annual Income, $ -7,440 K
  • 36-Month Beta -1.21
  • Price/Sales 19.37
  • Price/Cash Flow N/A
  • Price/Book 26.84
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.11
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/13/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4032 +24.01%
on 11/30/18
0.5700 -12.28%
on 11/26/18
-0.0100 (-1.96%)
since 11/14/18
3-Month
0.3900 +28.21%
on 10/25/18
0.7000 -28.57%
on 09/17/18
-0.1300 (-20.63%)
since 09/14/18
52-Week
0.3840 +30.21%
on 08/13/18
1.0200 -50.98%
on 12/15/17
-0.4800 (-48.98%)
since 12/14/17

Most Recent Stories

More News
PURE Bioscience Reports Fiscal 2019 Q1 Financial Results

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter...

PURE : 0.5000 (+4.17%)
PureCircle Plans Sale of New Stevia Products: Protein, Fiber and Antioxidant Ingredients

These, Added to the Company's Sweetener Lineup, Will Make Each Stevia Leaf 'Work Harder'

STEV : 0.0024 (-17.24%)
PURE : 0.5000 (+4.17%)
PURE Bioscience Sets Fiscal 2019 Q1 Financial Results Conference Call

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 13, 2018 the Company will file...

PURE : 0.5000 (+4.17%)
PURE Bioscience to Present at the 11th Annual LD Micro Conference

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that Hank R. Lambert, CEO, will present at the...

PURE : 0.5000 (+4.17%)
PURE Bioscience Reports Fiscal 2018 Year-End Financial Results

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal year ended July...

PURE : 0.5000 (+4.17%)
PURE Bioscience Appoints Chief Operating Officer

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that Tom Myers has been promoted to Chief Operating...

PURE : 0.5000 (+4.17%)
PureCircle and North Carolina Farmers Soon Harvest Company's First Commercial StarleafTM Stevia Crop Grown in the U.S.

Follows Successful Growing Season With Partner Farmers

STEV : 0.0024 (-17.24%)
PURE : 0.5000 (+4.17%)
PureCircle and North Carolina Farmers Soon Harvest Company's First Commercial Starleaf Stevia Crop Grown in the U.S.

PureCircle (LSE: PURE), the world's leading producer and innovator of stevia sweeteners, and its North Carolina farmer partners are about to harvest the company's first commercial-scale crop of Starleaf(TM)...

STEV : 0.0024 (-17.24%)
PURE : 0.5000 (+4.17%)
PURE Bioscience Responds to the Latest Foodborne Illness Outbreak Tied to Romaine Lettuce

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today responded to the current widespread foodborne illness outbreak...

PURE : 0.5000 (+4.17%)
PureCircle's Advances Now Enable It to Greatly Expand Production of Best-Tasting Stevia Sweeteners for Beverage and Food Companies

PureCircle's Advances Now Enable It to Greatly Expand Production of Best-Tasting Stevia Sweeteners for Beverage and Food Companies

STEV : 0.0024 (-17.24%)
PURE : 0.5000 (+4.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade PURE with:

Key Turning Points

2nd Resistance Point 0.5533
1st Resistance Point 0.5267
Last Price 0.5000
1st Support Level 0.4467
2nd Support Level 0.3933

See More

52-Week High 1.0200
Fibonacci 61.8% 0.7770
Fibonacci 50% 0.7020
Fibonacci 38.2% 0.6270
Last Price 0.5000
52-Week Low 0.3840

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar